Revenue | ₹68.97Cr |
Net Profits | ₹0.29Cr |
Net Profit Margins | 0.42% |
Balaxi Pharmaceuticals Ltd’s revenue jumped 8.15% since last year same period to ₹68.97Cr in the Q1 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -7.51% fall in its revenue since last 3-months.
Balaxi Pharmaceuticals Ltd’s net profit fell -95.52% since last year same period to ₹0.29Cr in the Q1 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -96.64% fall in its net profits since last 3-months.
Balaxi Pharmaceuticals Ltd’s net profit margin fell -95.86% since last year same period to 0.42% in the Q1 2025-2026. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated -96.37% fall in its net profit margins since last 3-months.
The revenue for Balaxi Pharmaceuticals Ltd in the Q1 results 2025 was ₹68.97Cr.
The net profit for Balaxi Pharmaceuticals Ltd in the Q1 results 2025 was ₹0.29Cr.
The net profit margin for Balaxi Pharmaceuticals Ltd in the Q1 results 2025 was 0.42%.
The revenue for Balaxi Pharmaceuticals Ltd in the Q1 results 2024 was ₹63.77Cr.
The net profit for Balaxi Pharmaceuticals Ltd in the Q1 results 2024 was ₹6.48Cr.
The net profit margin for Balaxi Pharmaceuticals Ltd in the Q1 results 2024 was 10.16%.